Casey C. Kopczynski - Mar 18, 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Chief Scientific Officer
Signature
/s/ John LaRocca, Attorney-In-Fact for Casey Kopczynski
Stock symbol
AERI
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
4
Date filed
3/22/2022, 08:32 PM
Previous filing
Feb 9, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +19K +7.28% $0.00 280K Mar 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +65.9K $0.00 65.9K Mar 18, 2022 Common Stock 65.9K $8.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of March 18, 2022.
F2 This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of March 18, 2022.